advertisement
Home » Bipolar Disorder » Blogs » Bipolar Beat » FDA Update on the Use of Antipsychotics During Pregnancy

FDA Update on the Use of Antipsychotics During Pregnancy

pregnancy and antipsychotic drugs

The U.S. Food and Drug Administration (FDA) is informing healthcare professionals that it has updated the Pregnancy section of drug labels for the entire class of antipsychotic drugs. The new drug labels now contain more and consistent information about the potential risk for abnormal muscle movements (extrapyramidal signs or EPS) and withdrawal symptoms in newborns whose mothers were treated with these drugs during the third trimester of pregnancy.

For details, see http://www.fda.gov/Drugs/DrugSafety/ucm243903.htm

Important: Do not stop taking your antipsychotic medication if you become pregnant. Consult your healthcare professional before making any changes to your medication. Abruptly stopping antipsychotic medication can cause significant complications in your treatment.

Photo by Frank de Kleine, available under a Creative Commons attribution license.

FDA Update on the Use of Antipsychotics During Pregnancy

Candida Fink, MD


One comment: View Comments / Leave a Comment

 

 

APA Reference
Fink, C. (2011). FDA Update on the Use of Antipsychotics During Pregnancy. Psych Central. Retrieved on August 22, 2018, from https://blogs.psychcentral.com/bipolar/2011/02/fda-warning-antipsychotics-pregnancy/

 

Last updated: 20 Apr 2011
Last reviewed: By John M. Grohol, Psy.D. on 20 Apr 2011
Published on PsychCentral.com. All rights reserved.